NPI: 1245520386 · ORLANDO, FL 32827 · Children' s Chronic Disease Hospital · NPI assigned 04/11/2011
Authorized official MCKENDREE, RODNEY controls 16+ related entities in our dataset. Read more
| Authorized Official | MCKENDREE, RODNEY (VP, FINANCE) |
| Parent Organization | THE NEMOURS FOUNDATION |
| NPI Enumeration Date | 04/11/2011 |
Other providers sharing the same authorized official: MCKENDREE, RODNEY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,250 | $514K |
| 2019 | 124,380 | $19.74M |
| 2020 | 100,139 | $17.81M |
| 2021 | 156,942 | $24.60M |
| 2022 | 121,911 | $14.22M |
| 2023 | 86,722 | $16.70M |
| 2024 | 48,296 | $11.37M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 58,509 | 55,402 | $16.97M |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 18,398 | 12,674 | $14.07M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 33,777 | 32,389 | $9.31M |
| A9150 | Non-prescription drugs | 10,923 | 8,114 | $6.35M |
| J3490 | Unclassified drugs | 52,426 | 24,411 | $5.28M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 14,375 | 4,372 | $3.52M |
| G0378 | Hospital observation service, per hour | 13,253 | 5,582 | $3.09M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2,758 | 2,566 | $2.88M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,362 | 8,811 | $2.50M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1,431 | 1,304 | $2.22M |
| J2704 | Injection, propofol, 10 mg | 17,641 | 14,524 | $2.05M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10,075 | 2,755 | $2.04M |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 19,475 | 14,217 | $1.70M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,997 | 3,144 | $1.54M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,710 | 2,586 | $1.53M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,351 | 2,882 | $1.48M |
| 54300 | 907 | 883 | $1.27M | |
| 42830 | 566 | 532 | $1.17M | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 7,183 | 6,673 | $1.14M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1,532 | 1,469 | $1.03M |
| 76770 | 4,062 | 3,891 | $906K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3,063 | 2,957 | $863K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,684 | 3,189 | $829K |
| J3480 | Injection, potassium chloride, per 2 meq | 3,578 | 2,142 | $738K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,575 | 1,080 | $687K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,266 | 1,192 | $659K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,080 | 1,726 | $647K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 2,005 | 1,911 | $616K |
| 80053 | Comprehensive metabolic panel | 10,034 | 6,671 | $598K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,367 | 1,313 | $585K |
| 54161 | 897 | 848 | $582K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,331 | 1,508 | $534K |
| 97161 | 1,768 | 1,702 | $505K | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 3,695 | 1,925 | $484K |
| 71046 | Radiologic examination, chest; 2 views | 6,414 | 5,974 | $483K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,179 | 1,864 | $463K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,460 | 2,369 | $452K |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 2,239 | 1,447 | $372K |
| 93304 | 643 | 564 | $356K | |
| 74018 | 6,135 | 5,483 | $354K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,277 | 1,250 | $354K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7,086 | 6,599 | $347K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,004 | 983 | $322K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 550 | 504 | $314K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,330 | 1,152 | $311K |
| 96367 | 455 | 370 | $277K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,361 | 3,037 | $271K |
| J3535 | Drug administered through a metered dose inhaler | 1,707 | 1,512 | $261K |
| 73090 | 1,832 | 1,493 | $255K | |
| 01922 | 1,733 | 1,625 | $250K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,467 | 2,032 | $247K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6,150 | 5,955 | $238K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,286 | 3,131 | $223K |
| 72082 | 2,610 | 2,567 | $222K | |
| 86900 | 2,130 | 1,614 | $210K | |
| 92523 | 820 | 801 | $198K | |
| 72170 | 2,457 | 2,396 | $198K | |
| 74230 | 717 | 705 | $197K | |
| 76536 | 1,128 | 1,096 | $183K | |
| 87631 | 2,153 | 2,088 | $171K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 236 | 224 | $165K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 118 | 115 | $161K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,936 | 10,676 | $156K |
| 70360 | 1,731 | 1,663 | $152K | |
| 73610 | 1,292 | 1,233 | $151K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 716 | 693 | $148K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 447 | 429 | $145K |
| 97166 | 539 | 535 | $144K | |
| J3262 | Injection, tocilizumab, 1 mg | 274 | 211 | $143K |
| 77072 | 1,497 | 1,480 | $134K | |
| 87275 | 1,868 | 1,776 | $127K | |
| 76870 | 780 | 744 | $126K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 283 | 188 | $124K |
| 73630 | 1,402 | 1,311 | $119K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 18,233 | 16,663 | $115K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 15,750 | 14,358 | $113K |
| 67311 | 28 | 25 | $113K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,447 | 2,026 | $109K |
| 74240 | 747 | 727 | $107K | |
| 93975 | 539 | 518 | $107K | |
| 54640 | 68 | 65 | $107K | |
| 36430 | 337 | 263 | $107K | |
| 00126 | 1,486 | 1,352 | $104K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 670 | 630 | $100K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 447 | 367 | $99K |
| 72081 | 1,162 | 1,150 | $95K | |
| 29888 | 13 | 12 | $94K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,500 | 983 | $90K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 3,751 | 3,483 | $88K |
| 44970 | 12 | 12 | $88K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,635 | 1,894 | $88K |
| 73080 | 629 | 580 | $88K | |
| 96415 | 595 | 468 | $85K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 743 | 712 | $85K |
| 82657 | 569 | 513 | $80K | |
| 72141 | 542 | 535 | $78K | |
| 74019 | 2,929 | 2,645 | $78K | |
| 73590 | 919 | 805 | $76K | |
| 82962 | 3,764 | 2,296 | $75K | |
| 12011 | 310 | 300 | $75K | |
| 81025 | 3,349 | 2,963 | $75K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 4,372 | 4,238 | $74K |
| 92526 | 943 | 263 | $74K | |
| 73140 | 633 | 571 | $74K | |
| 77073 | 992 | 962 | $72K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 683 | 667 | $72K |
| 97162 | 335 | 332 | $71K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,045 | 4,765 | $66K |
| 71045 | Radiologic examination, chest; single view | 3,162 | 2,940 | $66K |
| 73562 | 623 | 603 | $66K | |
| 87486 | 1,056 | 882 | $65K | |
| 93325 | 3,238 | 2,972 | $64K | |
| 95716 | 87 | 70 | $63K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,390 | 2,183 | $62K |
| 92630 | 467 | 203 | $62K | |
| 86140 | 2,978 | 2,528 | $61K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 10,375 | 8,467 | $61K |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,830 | 2,755 | $58K |
| 73130 | 522 | 488 | $57K | |
| 76000 | 1,396 | 1,231 | $54K | |
| 87077 | 1,155 | 986 | $54K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 6,709 | 5,683 | $47K |
| 97535 | Self-care/home management training, each 15 minutes | 775 | 388 | $40K |
| 96409 | 178 | 125 | $38K | |
| L8699 | Prosthetic implant, not otherwise specified | 786 | 628 | $36K |
| 73552 | 508 | 477 | $36K | |
| 69610 | 15 | 15 | $34K | |
| 88300 | 1,995 | 1,811 | $33K | |
| 81003 | 3,136 | 2,849 | $33K | |
| 00920 | 1,691 | 1,613 | $29K | |
| 76882 | 344 | 323 | $29K | |
| 36415 | Collection of venous blood by venipuncture | 231 | 193 | $28K |
| 74455 | 68 | 67 | $27K | |
| 81001 | 5,379 | 4,926 | $26K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 130 | 123 | $26K |
| 73560 | 351 | 330 | $25K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,363 | 849 | $23K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 510 | 416 | $23K |
| 93308 | 41 | 38 | $22K | |
| 89050 | 251 | 193 | $22K | |
| 94618 | 61 | 61 | $21K | |
| 97032 | 79 | 38 | $21K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 357 | 315 | $20K |
| G0379 | Direct admission of patient for hospital observation care | 1,465 | 1,299 | $20K |
| 74241 | 160 | 155 | $19K | |
| 87420 | 210 | 200 | $18K | |
| 97116 | 166 | 71 | $17K | |
| 72197 | 26 | 26 | $16K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,988 | 2,659 | $15K |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | 93 | 68 | $14K |
| 95700 | 71 | 66 | $14K | |
| J7510 | Prednisolone oral, per 5 mg | 61 | 56 | $14K |
| 31622 | 13 | 13 | $13K | |
| 76885 | 70 | 68 | $13K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 279 | 268 | $13K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 120 | 119 | $12K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,058 | 884 | $12K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 184 | 178 | $11K |
| 73521 | 91 | 90 | $11K | |
| 36591 | 1,608 | 990 | $11K | |
| 94010 | 251 | 241 | $11K | |
| 87070 | 584 | 491 | $11K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 82 | 81 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 608 | 237 | $10K |
| 93976 | 922 | 836 | $10K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 5,740 | 5,025 | $9K |
| 80305 | 325 | 307 | $9K | |
| 00300 | 403 | 369 | $9K | |
| 70480 | 53 | 52 | $9K | |
| 87507 | 270 | 260 | $8K | |
| 00400 | 97 | 85 | $8K | |
| 97165 | 61 | 60 | $8K | |
| 93017 | 44 | 41 | $8K | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 196 | 119 | $8K |
| 93000 | 308 | 298 | $8K | |
| 92610 | 25 | 25 | $8K | |
| 72146 | 435 | 430 | $8K | |
| 85610 | 648 | 512 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,417 | 3,991 | $6K |
| 96450 | 18 | 15 | $6K | |
| 92611 | 761 | 747 | $6K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 794 | 484 | $6K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 14 | 13 | $6K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 23 | 20 | $5K |
| 88304 | 754 | 661 | $5K | |
| 87040 | 2,103 | 1,795 | $5K | |
| 00731 | 713 | 685 | $5K | |
| 51600 | 56 | 55 | $5K | |
| 77080 | 45 | 42 | $5K | |
| 00120 | 266 | 248 | $5K | |
| 82803 | 728 | 556 | $5K | |
| 94664 | 313 | 290 | $5K | |
| 93320 | 1,472 | 1,400 | $4K | |
| 86885 | 2,104 | 1,604 | $4K | |
| 86901 | 2,104 | 1,604 | $4K | |
| 92015 | Determination of refractive state | 137 | 117 | $4K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,171 | 920 | $4K |
| 92567 | 177 | 173 | $3K | |
| 75561 | 12 | 12 | $3K | |
| 72100 | 73 | 72 | $3K | |
| 85651 | 1,704 | 1,474 | $3K | |
| 73070 | 29 | 27 | $3K | |
| 86850 | 1,633 | 1,260 | $3K | |
| 73564 | 25 | 25 | $3K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,192 | 1,124 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | 2,898 | 2,439 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,313 | 4,645 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 200 | 185 | $3K |
| 87045 | 12 | 12 | $2K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 30 | 25 | $2K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 352 | 209 | $2K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,704 | 1,519 | $2K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 1,615 | 839 | $2K |
| 84439 | 30 | 25 | $2K | |
| 74270 | 12 | 12 | $2K | |
| 49452 | 48 | 48 | $2K | |
| 86923 | 502 | 389 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,128 | 912 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13 | 13 | $2K |
| 97533 | 72 | 29 | $2K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,738 | 1,265 | $2K |
| 92060 | 16 | 16 | $2K | |
| 84703 | 94 | 88 | $2K | |
| 69210 | 12 | 12 | $1K | |
| 97542 | 14 | 12 | $1K | |
| 85045 | 1,055 | 785 | $1K | |
| 87581 | 1,056 | 882 | $1K | |
| 73110 | 27 | 25 | $1K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 3,272 | 2,993 | $1K |
| 83690 | 1,216 | 990 | $1K | |
| 83735 | 871 | 602 | $1K | |
| 84484 | 349 | 330 | $1K | |
| 73100 | 13 | 12 | $1K | |
| 82150 | 230 | 187 | $1K | |
| 83880 | 273 | 260 | $836.42 | |
| 87430 | 16 | 16 | $828.94 | |
| 93321 | 958 | 856 | $794.75 | |
| 82728 | 376 | 326 | $764.47 | |
| 73060 | 12 | 12 | $751.42 | |
| 87276 | 1,863 | 1,773 | $737.68 | |
| 74183 | 12 | 12 | $642.74 | |
| 73030 | 28 | 27 | $640.50 | |
| 00124 | 12 | 12 | $518.01 | |
| J7999 | Compounded drug, not otherwise classified | 464 | 377 | $500.69 |
| 82438 | 13 | 12 | $431.36 | |
| 73000 | 17 | 16 | $417.83 | |
| 87186 | 957 | 852 | $386.12 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 13 | 12 | $345.42 |
| 92652 | 27 | 27 | $338.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,497 | 1,143 | $337.20 |
| 86308 | 14 | 12 | $214.71 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 75 | 75 | $202.33 |
| 70250 | 12 | 12 | $164.94 | |
| 84100 | 752 | 523 | $153.50 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 648 | 450 | $127.03 |
| 88342 | 108 | 106 | $119.14 | |
| 76376 | 493 | 464 | $99.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,145 | 847 | $97.71 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,429 | 1,260 | $78.39 |
| 85730 | 572 | 445 | $69.94 | |
| J9370 | Vincristine sulfate, 1 mg | 387 | 235 | $61.30 |
| 84156 | 61 | 57 | $57.56 | |
| 82570 | 85 | 72 | $57.56 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 643 | 549 | $33.08 |
| S0028 | Injection, famotidine, 20 mg | 691 | 368 | $33.08 |
| 00140 | 119 | 117 | $32.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 116 | 92 | $27.12 |
| 84443 | Thyroid stimulating hormone (TSH) | 58 | 52 | $21.48 |
| 00840 | 91 | 84 | $21.32 | |
| 96376 | 273 | 139 | $17.09 | |
| 88108 | 31 | 26 | $10.66 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 477 | 453 | $5.88 |
| 00813 | 91 | 86 | $5.88 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 56 | 31 | $5.33 |
| 88302 | 12 | 12 | $5.33 | |
| 85384 | 31 | 30 | $5.08 | |
| 83615 | 122 | 113 | $3.22 | |
| 84550 | 55 | 51 | $3.22 | |
| 85379 | 42 | 36 | $0.00 | |
| 85660 | 62 | 51 | $0.00 | |
| 86905 | 120 | 79 | $0.00 | |
| 80329 | 16 | 12 | $0.00 | |
| J2430 | Injection, pamidronate disodium, per 30 mg | 27 | 25 | $0.00 |
| 82550 | 88 | 63 | $0.00 | |
| 83021 | 45 | 39 | $0.00 | |
| 87046 | 14 | 12 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 12 | 12 | $0.00 |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | 22 | 15 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 15 | 14 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 301 | 295 | $0.00 |
| 84145 | 91 | 83 | $0.00 | |
| 95873 | 31 | 26 | $0.00 | |
| J7699 | Noc drugs, inhalation solution administered through dme | 15 | 12 | $0.00 |
| 01470 | 12 | 12 | $0.00 | |
| 29125 | 14 | 14 | $0.00 | |
| 92585 | 26 | 24 | $0.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 18 | 17 | $0.00 |
| J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg | 26 | 25 | $0.00 |
| J9260 | Injection, methotrexate sodium, 50 mg | 17 | 13 | $0.00 |
| S0030 | Injection, metronidazole, 500 mg | 18 | 12 | $0.00 |
| 93356 | 28 | 27 | $0.00 | |
| A4649 | Surgical supply; miscellaneous | 22 | 12 | $0.00 |
| 87641 | 18 | 12 | $0.00 |